Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 4,053
- 试验地点
- 1
- 主要终点
- To establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines, overall and by country.
研究概览
简要总结
The purpose of the study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III/updated 2004 NCEP ATP III guidelines, overall and by country, in the following sub-populations:
- Primary/secondary prevention patients.
- Patients with metabolic syndrome (according to NCEP III definition).
In addition, the purpose is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task Force guidelines/national guidelines, in the survey population and in the following sub-populations:
- Primary/secondary prevention patients.
- Patients with metabolic syndrome.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •On lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks. ·
- •Subject must sign informed consent
排除标准
- •Subjects who are unwilling or unable to provide informed consent.
结局指标
主要结局
To establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines, overall and by country.
时间窗: 6 months- One visit only, no follow up visits.
次要结局
- The proportion of patients reaching the LDL-C goals according to the Third Joint European Task Force guidelines / national guidelines, in the following sub-populations:-Primary/secondary prevention patients -Patients with metabolic syndrome.(6 months- One visit only, no follow up visits.)
- The proportion of patients reaching the LDL-C goals according to the NCEP ATP III/updated 2004 NCEP ATP III in the following sub-populations - Primary/secondary prevention patients - Patients with metabolic syndrome (according to NCEP III definition).(6 months - One visit only, no follow up visits.)